Works by Massey, Dan

Results: 12

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6.

Published in:

2017

By:

Wu, Yi-Long;
Sequist, Lecia V;
Hu, Cheng-Ping;
Feng, Jifeng;
Lu, Shun;
Huang, Yunchao;
Li, Wei;
Hou, Mei;
Schuler, Martin;
Mok, Tony;
Yamamoto, Nobuyuki;
O'Byrne, Kenneth;
Hirsh, Vera;
Gibson, Neil;
Massey, Dan;
Kim, Miyoung;
Yang, James Chih-Hsin

Publication type:

journal article

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3.

Published in:

Cancer Science, 2015, v. 106, n. 9, p. 1202, doi. 10.1111/cas.12723

By:

Kato, Terufumi;
Yoshioka, Hiroshige;
Okamoto, Isamu;
Yokoyama, Akira;
Hida, Toyoaki;
Seto, Takashi;
Kiura, Katsuyuki;
Massey, Dan;
Seki, Yoko;
Yamamoto, Nobuyuki

Publication type:

Article

Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR.

Published in:

Oncologist, 2014, v. 19, n. 7, p. 702, doi. 10.1634/theoncologist.2013-0419

By:

Ahn, Myung‐Ju;
Kim, Sang‐We;
Cho, Byoung‐Chul;
Ahn, Jin Seok;
Lee, Dae Ho;
Sun, Jong‐Mu;
Massey, Dan;
Kim, Miyoung;
Shi, Yang;
Park, Keunchil

Publication type:

Article

Lansoprazole and amoxycillin: Observations on the treatment of Helicobacter pylori infection.

Published in:

Journal of Gastroenterology & Hepatology, 1997, v. 12, n. 2, p. 93, doi. 10.1111/j.1440-1746.1997.tb00390.x

By:

HAZELL, STUART L;
DASKALOPOULOUS, GEORGE;
MITCHELL, HAZEL M;
MASSEY, DAN

Publication type:

Article

Characterization of gut microbiomes of household pets in the United States using a direct-to-consumer approach.

Published in:

PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0227289

By:

Jha, Aashish R.;
Shmalberg, Justin;
Tanprasertsuk, Jirayu;
Perry, LeeAnn;
Massey, Dan;
Honaker, Ryan W.

Publication type:

Article

Deploying Cryptography in Internet-Scale Systems: A Case Study on DNSSEC.

Published in:

2011

By:

Yang, Hao;
Osterweil, Eric;
Massey, Dan;
Lu, Songwu;
Zhang, Lixia

Publication type:

Case Study

Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY.

Published in:

Clinical & Experimental Nephrology, 2024, v. 28, n. 6, p. 588, doi. 10.1007/s10157-024-02489-4

By:

Nangaku, Masaomi;
Herrington, William G.;
Goto, Shinya;
Maruyama, Shoichi;
Kashihara, Naoki;
Ueki, Kohjiro;
Wada, Jun;
Watada, Hirotaka;
Nakashima, Eitaro;
Lee, Ryonfa;
Massey, Dan;
Mayne, Kaitlin J.;
Tomita, Aiko;
Haynes, Richard;
Hauske, Sibylle J.;
Kadowaki, Takashi

Publication type:

Article

First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.

Published in:

Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x

By:

Schuler, Martin;
Tan, Eng-Huat;
O'Byrne, Kenneth;
Zhang, Li;
Boyer, Michael;
Mok, Tony;
Hirsh, Vera;
Yang, James Chih-Hsin;
Lee, Ki Hyeong;
Lu, Shun;
Shi, Yuankai;
Kim, Sang-We;
Laskin, Janessa;
Kim, Dong-Wan;
Arvis, Catherine Dubos;
Kölbeck, Karl;
Massey, Dan;
Märten, Angela;
Paz-Ares, Luis;
Park, Keunchil

Publication type:

Article

Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies.

Published in:

International Journal of COPD, 2010, v. 5, p. 197

By:

Bateman, Eric;
Singh, Dave;
Smith, David;
Disse, Bernd;
Towse, Lesley;
Massey, Dan;
Blatchford, Jon;
Pavia, Demetri;
Hodder, Rick

Publication type:

Article

Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997-2001.

Published in:

International Journal of COPD, 2006, v. 1, n. 4, p. 435, doi. 10.2147/copd.2006.1.4.435

By:

Pearson, Mike;
Ayres, Jon G.;
Sarno, Maria;
Massey, Dan;
Price, David

Publication type:

Article

Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6).

Published in:

Patient, 2018, v. 11, n. 1, p. 131, doi. 10.1007/s40271-017-0287-z

By:

Wu, Yi-Long;
Hirsh, Vera;
Sequist, Lecia;
Hu, Cheng-Ping;
Feng, Jifeng;
Lu, Shun;
Huang, Yunchao;
Schuler, Martin;
Mok, Tony;
Yamamoto, Nobuyuki;
O'Byrne, Kenneth;
Geater, Sarayut;
Zhou, Caicun;
Massey, Dan;
Märten, Angela;
Lungershausen, Juliane;
Yang, James

Publication type:

Article

XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.

Published in:

Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01649-w

By:

Schmid, Peter;
Cortes, Javier;
Joaquim, Ana;
Jañez, Noelia Martínez;
Morales, Serafín;
Díaz-Redondo, Tamara;
Blau, Sibel;
Neven, Patrick;
Lemieux, Julie;
García-Sáenz, José Ángel;
Hart, Lowell;
Biyukov, Tsvetan;
Baktash, Navid;
Massey, Dan;
Burris III, Howard A.;
Rugo, Hope S.

Publication type:

Article